title: Somatostatin analogue SMS 201-995 in the short-term management of neonatal hyperinsulinism due to nesidioblastosis.
abstract: A neonate with persistent hyperinsulinaemic hypoglycaemia is presented in whom the use of intravenous somatostatin SMS 201-995 allowed good glycaemic control over 10 days. A 95% pancreatectomy was then performed.
authors.affiliation: Department of Paediatrics, University of Otago Medical School, Dunedin, New Zealand.
authors.forename: M J
authors.initials: MJ
authors.lastname: Sullivan
authors.forename: B J
authors.initials: BJ
authors.lastname: Taylor
authors.forename: R S
authors.initials: RS
authors.lastname: Broadbent
authors.forename: K
authors.initials: K
authors.lastname: Yun
authors.forename: M
authors.initials: M
authors.lastname: Lovell-Smith
authors.forename: R A
authors.initials: RA
authors.lastname: Donald
mesh_terms: D001786:Blood Glucose / Q000378:metabolism; D006801:Humans; D006946:Hyperinsulinism / Q000188:drug therapy* / Q000473:pathology; D007003:Hypoglycemia / Q000188:drug therapy; D007231:Infant, Newborn; D007262:Infusions, Intravenous; D007515:Islets of Langerhans / Q000473:pathology; D008297:Male; D008854:Microscopy, Electron; D015282:Octreotide / Q000627:therapeutic use*; D010179:Pancreas / Q000473:pathology; D010180:Pancreatectomy; D010182:Pancreatic Diseases / Q000150:complications* / Q000473:pathology / Q000601:surgery; D011183:Postoperative Complications / Q000188:drug therapy
chemical_list: D001786:Blood Glucose; D015282:Octreotide